TOP TIERMARKET NEWSWIRE
SEC Form 4 history

SPYRE THERAPEUTICS I (SYRE) insider trades

SPYRE THERAPEUTICS I (SYRE) insider trading activity (SEC Form 4). Over the trailing 90 days, SYRE insiders filed 0 purchases totalling $0 and 12 sales totalling $416.0M — net SELLING of $416.0M. Most recent filing: Aug 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
12
$416.0M
Net (90d)
-$416.0M
net selling
Most recent
Aug 5, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 5, 2026Burrows Scott LCFOS SaleOE—$95.57$717Kfiling
Aug 5, 2026Turtle CameronCEOS Sale—$95.51$1.4Mfiling
Jul 2, 2026Burrows Scott LCFOS SaleOE—$87.74$658Kfiling
Jul 2, 2026Turtle CameronCEOS Sale—$87.69$1.3Mfiling
Jul 2, 2026Sloan SheldonChief Medical OfficerS SaleOE—$87.70$731Kfiling
Jun 26, 2026Burrows Scott LCFOS SaleOE—$87.13$1.3Mfiling
Jun 23, 2026Fairmount Funds Management LLCDirS SaleOE—$85.31$399.7Mfiling
Jun 23, 2026Henderson Michael ThomasDirS Sale—$100.00$2.0Mfiling
Jun 3, 2026Sloan SheldonChief Medical OfficerS SaleOE—$75.00$625Kfiling
Jun 3, 2026Burrows Scott LCFOS SaleOE—$71.06$533Kfiling
Jun 3, 2026Turtle CameronCEOS Sale—$70.43$1.1Mfiling
May 8, 2026Henderson Michael ThomasDirS Sale—$74.40$6.0Mfiling